Literature DB >> 8199986

Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia.

G Y Lauwers1, G V Scott, J Hendricks.   

Abstract

BACKGROUND: bcl-2 protein encoded by the proto-oncogene bcl-2 confers to the cell a survival advantage by inhibiting apoptosis. Its aberrant expression has been reported in lymphomas and lung carcinoma. To determine if bcl-2 plays a role in the gastric carcinogenic sequence, the authors studied bcl-2 expression in gastric epithelial dysplasia (GED) and chronic atrophic gastritis with intestinal metaplasia (CAG-IM).
METHODS: Immunohistochemical staining using monoclonal bcl-2 protein antibody, clone 124, was performed on archival material.
RESULTS: bcl-2 staining was seen in 13 of 16 GEDs (81%). The staining was heterogeneous, suggesting that within the dysplastic epithelium, some cellular clones may have a survival advantage. When noted, the staining in IM was located in the proliferative zone, but some positivity could also be noted higher up along the cellular escalator. Normal gastric mucosa stained in the proliferative zone.
CONCLUSIONS: The authors demonstrated that bcl-2 expression is noted in GED as well as in the extended proliferative zone of CAG-IM. This suggests that prolonged cell survival due to inhibition of apoptosis is instrumental in addition to increased cellular proliferation in the altered cellular homeostasis of the gastric carcinogenic sequence. Whether bcl-2 protein aberrant expression is an independent process or inherent to immaturity of the cells produced by the increased proliferation awaits further studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199986     DOI: 10.1002/1097-0142(19940615)73:12<2900::aid-cncr2820731205>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Molecular mechanisms of H. pylori associated gastric carcinogenesis.

Authors:  Zun-Wu Zhang; Michael JG Farthing
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Transretinoic acid inhibits rats gastric epithelial dysplasia induced by N-methyl-N-nitro-N-nitrosoguanidine: influences on cell apoptosis and expression of its regulatory genes.

Authors:  R T Cui; G Cai; Z B Yin; Y Cheng; Q H Yang; T Tian
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

3.  Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival.

Authors:  P Stattin; J E Damber; L Karlberg; H Nordgren; A Bergh
Journal:  Urol Res       Date:  1996

4.  Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event.

Authors:  Q L Lu; M Laniado; P D Abel; G W Stamp; E N Lalani
Journal:  Mol Pathol       Date:  1997-02

5.  Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide.

Authors:  Daniel A Ribeiro; Daisy M F Salvadori; Mariângela E A Marques
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

Review 6.  Histopathological evaluation of apoptosis in cancer.

Authors:  Y Soini; P Pääkkö; V P Lehto
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

7.  Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer.

Authors:  Y F Hu; I H Russo; U Zalipsky; H T Lynch; J Russo
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Jul-Aug       Impact factor: 2.416

Review 8.  Helicobacter pylori in gastric malignancies.

Authors:  Abhishek Bhandari; Sheila E Crowe
Journal:  Curr Gastroenterol Rep       Date:  2012-12

9.  Expression of bcl-2 in autoimmune and Helicobacter pylori-associated atrophic gastritis.

Authors:  Y Maor-Kendler; G Gabay; J Bernheim; T Naftali; I Lesin; G Leichtman; I Pomeranz; B Novis
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

10.  Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections?

Authors:  R Kopp; J Diebold; I Dreier; C Cramer; J Glas; G Baretton; K W Jauch
Journal:  Surg Endosc       Date:  2005-09-21       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.